Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

Affiliations

Elizabeth Margolskee: Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
Spencer Krichevsky: Richard T. Silver Center for Myeloproliferative Neoplasms, Division of Hematology/Medical Oncology, Weill Cornell Medicine, New York, NY, USA
Attilio Orazi: Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA
Richard T. Silver: Richard T. Silver Center for Myeloproliferative Neoplasms, Division of Hematology/Medical Oncology, Weill Cornell Medicine, New York, NY, USA

Abstract

No abstracts available.

ISSN: 0390-6078 (Print); 1592-8721 (Online)
Publisher: Ferrata Storti Foundation
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.haematologica.org